nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to specialized care and outcomes in adults with acute leukemias
|
Muffly, Lori |
|
|
4 |
7 |
p. 1538 |
artikel |
2 |
A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment
|
Sun, Yu-Yo |
|
|
4 |
7 |
p. 1222-1231 |
artikel |
3 |
Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia
|
Rambaldi, Alessandro |
|
|
4 |
7 |
p. 1518-1525 |
artikel |
4 |
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma
|
De Philippis, Chiara |
|
|
4 |
7 |
p. 1242-1249 |
artikel |
5 |
Chimeric antigen receptor–T cells with cytokine neutralizing capacity
|
Tan, Adrian H.J. |
|
|
4 |
7 |
p. 1419-1431 |
artikel |
6 |
Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells
|
Seng, Amara |
|
|
4 |
7 |
p. 1325-1339 |
artikel |
7 |
Comprehensive proteomic analysis of murine terminal erythroid differentiation
|
Gautier, Emilie-Fleur |
|
|
4 |
7 |
p. 1464-1477 |
artikel |
8 |
Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function
|
Milani, Paolo |
|
|
4 |
7 |
p. 1321-1324 |
artikel |
9 |
Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy
|
Bhatt, Meha |
|
|
4 |
7 |
p. 1250-1264 |
artikel |
10 |
Dimorphism in the TCRγ-chain repertoire defines 2 types of human immunity to Epstein-Barr virus
|
Djaoud, Zakia |
|
|
4 |
7 |
p. 1198-1205 |
artikel |
11 |
Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing
|
Smith, Samantha L. |
|
|
4 |
7 |
p. 1388-1406 |
artikel |
12 |
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines
|
Neumann, Ignacio |
|
|
4 |
7 |
p. 1512-1517 |
artikel |
13 |
Editorial Board
|
|
|
|
4 |
7 |
p. i |
artikel |
14 |
Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis
|
Lévy, Romain |
|
|
4 |
7 |
p. 1383-1387 |
artikel |
15 |
ERRATUM
|
|
|
|
4 |
7 |
p. 1217 |
artikel |
16 |
ERRATUM
|
|
|
|
4 |
7 |
p. 1219 |
artikel |
17 |
ERRATUM
|
|
|
|
4 |
7 |
p. 1220 |
artikel |
18 |
ERRATUM
|
|
|
|
4 |
7 |
p. 1221 |
artikel |
19 |
ERRATUM
|
|
|
|
4 |
7 |
p. 1197 |
artikel |
20 |
ERRATUM
|
|
|
|
4 |
7 |
p. 1218 |
artikel |
21 |
Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor
|
Holtan, Shernan G. |
|
|
4 |
7 |
p. 1284-1295 |
artikel |
22 |
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
|
Zhang, Xuhan |
|
|
4 |
7 |
p. 1307-1310 |
artikel |
23 |
Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice
|
Chappaz, Stéphane |
|
|
4 |
7 |
p. 1270-1283 |
artikel |
24 |
Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial
|
Schuster, Stephen J. |
|
|
4 |
7 |
p. 1432-1439 |
artikel |
25 |
Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial
|
Maziarz, Richard T. |
|
|
4 |
7 |
p. 1440-1447 |
artikel |
26 |
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity
|
Varma, Ankur |
|
|
4 |
7 |
p. 1296-1306 |
artikel |
27 |
Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia
|
Verneris, Michael R. |
|
|
4 |
7 |
p. 1350-1356 |
artikel |
28 |
IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP
|
Carcao, Manuel |
|
|
4 |
7 |
p. 1492-1500 |
artikel |
29 |
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma
|
Keane, Colm |
|
|
4 |
7 |
p. 1367-1377 |
artikel |
30 |
Late infectious complications in hematopoietic cell transplantation survivors: a population-based study
|
Foord, Aimee M. |
|
|
4 |
7 |
p. 1232-1241 |
artikel |
31 |
Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India
|
Dhanya, Rakesh |
|
|
4 |
7 |
p. 1448-1457 |
artikel |
32 |
Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation
|
Valladolid, Christian |
|
|
4 |
7 |
p. 1340-1349 |
artikel |
33 |
Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens
|
Lachowiez, Curtis A. |
|
|
4 |
7 |
p. 1311-1320 |
artikel |
34 |
Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice
|
Gruber, David R. |
|
|
4 |
7 |
p. 1526-1537 |
artikel |
35 |
Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors
|
Ryan, Christine E. |
|
|
4 |
7 |
p. 1458-1463 |
artikel |
36 |
Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes
|
Ritz, Caitlin |
|
|
4 |
7 |
p. 1378-1382 |
artikel |
37 |
Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire
|
Belhouachi, Nabila |
|
|
4 |
7 |
p. 1357-1366 |
artikel |
38 |
Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study
|
Niss, Omar |
|
|
4 |
7 |
p. 1501-1511 |
artikel |
39 |
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736
|
Moore, Andrew S. |
|
|
4 |
7 |
p. 1478-1491 |
artikel |
40 |
Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia
|
Abadir, Edward |
|
|
4 |
7 |
p. 1206-1216 |
artikel |
41 |
Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma
|
Pikman, Yana |
|
|
4 |
7 |
p. 1265-1269 |
artikel |
42 |
The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites
|
Mato, Anthony |
|
|
4 |
7 |
p. 1407-1418 |
artikel |
43 |
The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing
|
Dalton, W. Brian |
|
|
4 |
7 |
p. 1192-1196 |
artikel |
44 |
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis
|
Izcovich, Ariel |
|
|
4 |
7 |
p. 1539-1553 |
artikel |